CCL2 and Hepatic fibrosis: In a mouse model of liver fibrosis and hepatocarcinogenesis, CCL2 inhibition by an RNA aptamer resulted in reduced TAM1 liver infiltrate and pathogenic angiogenesis, improvement of tissue fibrosis, and a significant inhibition of tumor progression [145].